At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 10 enrolled
Drug / intervention
Zoster Vaccine Livedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immune Response to Shingles Vaccination
In Brief
A Phase 4 clinical trial evaluating Zoster Vaccine Live for Shingles. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsShingles
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartFeb 2016
Primary CompletionNov 2019
TodayJul 2026
First PostedDec 8, 2015
Enrollment StartFeb 1, 2016
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.6 years ago
Interventions
Zoster Vaccine Livedrug